Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,572,193
-
Total 13F shares
-
31,001,969
-
Share change
-
+15,429
-
Total reported value
-
$233,717,880
-
Put/Call ratio
-
67%
-
Price per share
-
$7.54
-
Number of holders
-
62
-
Value change
-
+$117,000
-
Number of buys
-
2
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q4 2013
As of 31 Dec 2013,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,001,969 shares.
The largest 10 holders included
NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ABINGWORTH LLP, Ameriprise Financial Inc, Orchard Hill Capital Management LP, ARDSLEY ADVISORY PARTNERS, MUTUAL OF AMERICA CAPITAL MANAGEMENT CORP, Healthcare Value Capital, LLC, BlackRock Fund Advisors, and ORBIMED ADVISORS LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.